Therefore, the AGE/RAGE axis could be considered to play an important clinical role in ARDS pathogenesis in COVID-19 and the use of RAGE pathway modulators must be considered as a possible treatment for the reduction of morbidity and mortality. This evidence concerns the gene AGER and acute respiratory distress syndrome.